BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer.
Mao
Chen
C
Liao
Ru-Yan
RY
Chen
Qing
Q
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology*; D066246:ErbB Receptors / Q000276:immunology*; D006801:Humans; D009154:Mutation; D009362:Neoplasm Metastasis / Q000235:genetics*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*
D000911:Antibodies, Monoclonal; D066246:ErbB Receptors; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf